Former footballer, David Beckham, has become a strategic investor in health sciences company, Prenetics, which pioneers scientific advancements in health.

The partners have co-founded a new health and wellness brand, IM8, that will be dedicated to creating cutting-edge consumer health products. It is likely the focus will be on innovations to impact global health and longevity.

Beckham says: "Throughout my life and career, I've been fortunate to have access to the best medical professionals, nutrition experts and fitness coaches. Their guidance has been crucial to my health and well-being. That’s why I am excited to be working with Prenetics – a company that is dedicated to innovative, world-leading scientific advancements in health – as a co-founding partner and ambassador for IM8.”

Danny Yeung, CEO and co-founder of Prenetics, says this partnership is transformational for Prenetics, global health innovation and wellness: “Working closely with David these past months, I've been consistently inspired by his vision for accessible health for all. His passion and commitment are truly extraordinary. With IM8, we have a unique opportunity to contribute meaningfully to the consumer health and wellness industry.”

In the talks preceding the investment, Beckham spent time with Prenetics shareholder and scientist, Professor Dennis Lo, who pioneered non-invasive prenatal testing which is now used by 15 million expectant mothers worldwide each year. Lo is now working with Prenetics on multi-cancer early detection technologies through the company’s clinical division.

Beckham’s footballing career spanned 20 years, during which time he captained England’s football team for six years and won league titles in England, Spain, the US and France. Since retiring in 2013 he has become a successful entrepreneur investing in many world leading brands including adidas and Nespresso. Despite a legal wrangle, Beckham remains a shareholder and ambassador with F45 Training.